Home About us R & D Products Manufacturing News Contact us 中文简体

Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号

Headquarter Address: 8888 Lvyou Road, Jinan, Shandong 250104, CHINA Powered by www.300.cn

Qilu Pharmaceutical ranked 5th among China's top 100 list

Qilu Pharmaceutical ranked 5th among China's top 100 list

Release time：
2022-07-18
The Most Socially Responsible Enterprises (Entrepreneurs) in 2021

The Most Socially Responsible Enterprises (Entrepreneurs) in 2021

Release time：
2022-06-15
Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

Release time：
2021-12-20
Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies

Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies

Release time：
2021-12-20
Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China

Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China

Release time：
2021-12-20
Abiraterone Acetate Tablets exported to US

Abiraterone Acetate Tablets exported to US

Release time：
2020-01-20
The first Avastin(Bevacizumab) Biosimilar approval in China granted by NMPA

The first Avastin(Bevacizumab) Biosimilar approval in China granted by NMPA

Release time：
2019-12-09
Qilu Pharmaceutical Ranks No. 8th among Top 100 Chinese Pharmaceutical Companies

Qilu Pharmaceutical Ranks No. 8th among Top 100 Chinese Pharmaceutical Companies

Release time：
2019-08-30
Qilu Pharmaceutical recognized as Top 3 domestic R&D pharmaceutical company of 2019

Qilu Pharmaceutical recognized as Top 3 domestic R&D pharmaceutical company of 2019

Release time：
2019-06-22
Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States

Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States

Release time：
2020-05-20